Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Financing › Details

Hookipa–SEVERAL: investment, 201903– IPO up to $86.3m at Nasdaq FILED

 

Period Period 2019-03-22
Region Region United States (USA)
  Predecessor Hookipa–SEVERAL: investment, 201902 financing round Series D €33.2m ($37.4m) led by Redmile Group + incl Invus + Samsara Capital et al.
Organisation Money taker Hookipa Pharma Inc.
  Group Hookipa (Group)
Products Product HB-101 (Hookipa)
  Product 2 investment banking
Document Source Eaton, Elizabeth S. [BioCentury]. (3/22/19). "News: Hookipa Proposes IPO as Its Cancer Vaccines Head towards the Clinic".
     

   
Record changed: 2019-03-24

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

More documents for Hookipa (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px




» top